CRMAX
Price
$12.86
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VEXMX
Price
$150.16
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

CRMAX vs VEXMX

Header iconCRMAX vs VEXMX Comparison
Open Charts CRMAX vs VEXMXBanner chart's image
CRM Small/Mid Cap Value I
Price$12.86
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Extended Market Index Investor
Price$150.16
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
CRMAX vs VEXMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CRMAX vs. VEXMX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMAX is a StrongBuy and VEXMX is a Buy.

FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 107B vs. CRMAX (187M). VEXMX pays higher dividends than CRMAX: VEXMX (1.09) vs CRMAX (0.59). CRMAX was incepted earlier than VEXMX: CRMAX (20 years) vs VEXMX (37 years). CRMAX is a more actively managed with annual turnover of: 42.00 vs. VEXMX (11.00). CRMAX has a lower initial minimum investment than VEXMX: CRMAX (2500) vs VEXMX (3000). VEXMX (36.13) and CRMAX (35.01) have marching annual gain over last year. VEXMX return over 5 years is better than : 64.75 vs. CRMAX (13.84).
CRMAXVEXMXCRMAX / VEXMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years37 years-
Gain YTD21.09220.569103%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets187M107B0%
Annual Yield % from dividends0.591.0954%
Returns for 1 year35.0136.1397%
Returns for 3 years-18.340.38-4,767%
Returns for 5 years13.8464.7521%
Returns for 10 years-26.26136.86-19%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNTS0.670.06
+9.30%
Momentus
HPP4.210.17
+4.21%
Hudson Pacific Properties
K81.180.15
+0.19%
Kellanova
WDFC285.73-4.39
-1.51%
WD-40 Company
NVCT10.67-0.31
-2.82%
Nuvectis Pharma